SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-18-107549
Filing Date
2018-04-04
Accepted
2018-04-04 16:32:58
Documents
48

Document Format Files

Seq Description Document Type Size
1 POS AM d331788dposam.htm POS AM 969489
2 EX-23.1 d331788dex231.htm EX-23.1 1530
9 GRAPHIC g331788g0331044458412.jpg GRAPHIC 8099
  Complete submission text file 0001193125-18-107549.txt   3081499

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT hppi-20171231.xml EX-101.INS 326126
4 XBRL TAXONOMY EXTENSION SCHEMA hppi-20171231.xsd EX-101.SCH 39186
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hppi-20171231_cal.xml EX-101.CAL 36128
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hppi-20171231_def.xml EX-101.DEF 152644
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE hppi-20171231_lab.xml EX-101.LAB 302054
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hppi-20171231_pre.xml EX-101.PRE 211957
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-212092 | Film No.: 18737625
SIC: 8731 Services-Commercial Physical & Biological Research